These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 9657198
1. Inhibition of Ras and related G-proteins as a therapeutic strategy for blocking malignant glioma growth. Bredel M, Pollack IF, Freund JM, Hamilton AD, Sebti SM. Neurosurgery; 1998 Jul; 43(1):124-31; discussion 131-2. PubMed ID: 9657198 [Abstract] [Full Text] [Related]
4. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE. Cancer Res; 2001 Dec 15; 61(24):8758-68. PubMed ID: 11751396 [Abstract] [Full Text] [Related]
5. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Sun J, Qian Y, Hamilton AD, Sebti SM. Oncogene; 1998 Mar 15; 16(11):1467-73. PubMed ID: 9525745 [Abstract] [Full Text] [Related]
9. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells. Stark WW, Blaskovich MA, Johnson BA, Qian Y, Vasudevan A, Pitt B, Hamilton AD, Sebti SM, Davies P. Am J Physiol; 1998 Jul 15; 275(1):L55-63. PubMed ID: 9688935 [Abstract] [Full Text] [Related]
10. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM. Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225 [Abstract] [Full Text] [Related]
11. The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells. Bolick SC, Landowski TH, Boulware D, Oshiro MM, Ohkanda J, Hamilton AD, Sebti SM, Dalton WS. Leukemia; 2003 Feb 07; 17(2):451-7. PubMed ID: 12592346 [Abstract] [Full Text] [Related]
12. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Vogt A, Qian Y, McGuire TF, Hamilton AD, Sebti SM. Oncogene; 1996 Nov 07; 13(9):1991-9. PubMed ID: 8934546 [Abstract] [Full Text] [Related]
13. Simvastatin-dependent apoptosis in Hodgkin's lymphoma cells and growth impairment of human Hodgkin's tumors in vivo. von Tresckow B, von Strandmann EP, Sasse S, Tawadros S, Engert A, Hansen HP. Haematologica; 2007 May 07; 92(5):682-5. PubMed ID: 17488694 [Abstract] [Full Text] [Related]
19. GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Miquel K, Pradines A, Sun J, Qian Y, Hamilton AD, Sebti SM, Favre G. Cancer Res; 1997 May 15; 57(10):1846-50. PubMed ID: 9157972 [Abstract] [Full Text] [Related]